BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND CDH11, OB, 1009, ENSG00000140937, CAD11, P55287
61 results:

  • 1. Title: Obesogenic microbial signatures and the development of obesity in childhood acute lymphoblastic leukemia.
    Park H; Uhlemann AC; Jacobs SS; Mowbray C; Jubelirer T; Kelly KM; Walters M; Ladas EJ
    Leuk Res; 2023 Mar; 126():107017. PubMed ID: 36641874
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Caloric and nutrient restriction to augment chemotherapy efficacy for acute lymphoblastic leukemia: the IDEAL trial.
    Orgel E; Framson C; Buxton R; Kim J; Li G; Tucci J; Freyer DR; Sun W; Oberley MJ; Dieli-Conwright C; Mittelman SD
    Blood Adv; 2021 Apr; 5(7):1853-1861. PubMed ID: 33792627
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Aberrant Bone Homeostasis in AML Is Associated with Activated Oncogenic FLT3-Dependent Cytokine Networks.
    Bär I; Ast V; Meyer D; König R; Rauner M; Hofbauer LC; Müller JP
    Cells; 2020 Nov; 9(11):. PubMed ID: 33182501
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Variations in hospitalization and emergency department/observation stays using the oncology care model methodology in Medicare data.
    Li S; Peng Y; Liu J; Li S; Raskin L; Kelsh MA; Zaha R; Gawade PL; Henry D; Lyman GH
    Curr Med Res Opin; 2020 Sep; 36(9):1519-1527. PubMed ID: 32715807
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Investigation of conformational dynamics of Tyr89Cys mutation in protection of telomeres 1 gene associated with familial melanoma.
    Amir M; Ahamad S; Mohammad T; Jairajpuri DS; Hasan GM; Dohare R; Islam A; Ahmad F; Hassan MI
    J Biomol Struct Dyn; 2021 Jan; 39(1):35-44. PubMed ID: 31847782
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Mode of progression after first line treatment correlates with outcome of chronic lymphocytic leukemia (CLL).
    Al-Sawaf O; Bazeos A; Robrecht S; Bahlo J; Gower C; Fink AM; Tresckow J; Cramer P; Langerbeins P; Kutsch N; Humphrey K; Fingerle-Rowson G; Stilgenbauer S; Wendtner CM; Fischer K; Eichhorst B; Hallek M; Goede V
    Am J Hematol; 2019 Sep; 94(9):1002-1006. PubMed ID: 31222797
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Discovery of donor genotype associated with long-term survival of patients with hematopoietic stem cell transplantation in refractory acute myeloid leukemia.
    Ock CY; Seo H; Kim DY; Min BJ; Park Y; Cheong HS; Kim HL; Song EY; Kim I; Yoon SS; Kim JH; Koh Y
    Leuk Lymphoma; 2019 Jul; 60(7):1775-1781. PubMed ID: 30507323
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Outcome of patients aged 80 years or older treated for chronic lymphocytic leukaemia.
    Al-Sawaf O; Bahlo J; Robrecht S; Fischer K; Herling CD; Hoechstetter M; Fink AM; von Tresckow J; Langerbeins P; Cramer P; Stilgenbauer S; Wendtner CM; Eichhorst B; Hallek M; Goede V
    Br J Haematol; 2018 Dec; 183(5):727-735. PubMed ID: 30460980
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. NT5C2 germline variants alter thiopurine metabolism and are associated with acquired NT5C2 relapse mutations in childhood acute lymphoblastic leukaemia.
    Tulstrup M; Grosjean M; Nielsen SN; Grell K; Wolthers BO; Wegener PS; Jonsson OG; Lund B; Harila-Saari A; Abrahamsson J; Vaitkeviciene G; Pruunsild K; Toft N; Holm M; Hulegårdh E; Liestøl S; Griskevicius L; Punab M; Wang J; Carroll WL; Zhang Z; Dalgaard MD; Gupta R; Nersting J; Schmiegelow K
    Leukemia; 2018 Dec; 32(12):2527-2535. PubMed ID: 30201983
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Motivating Cord Blood Donation with Information and Behavioral Nudges.
    Grieco D; Lacetera N; Macis M; Di Martino D
    Sci Rep; 2018 Jan; 8(1):252. PubMed ID: 29321654
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Structural and functional analysis of the human POT1-TPP1 telomeric complex.
    Rice C; Shastrula PK; Kossenkov AV; Hills R; Baird DM; Showe LC; Doukov T; Janicki S; Skordalakes E
    Nat Commun; 2017 Apr; 8():14928. PubMed ID: 28393830
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. ADAMTSL5 and cdh11: putative epigenetic markers for therapeutic resistance in acute lymphoblastic leukemia.
    Abdullah M; Choo CW; Alias H; Abdul Rahman EJ; Mohd Ibrahim H; Jamal R; Hussin NH
    Hematology; 2017 Aug; 22(7):386-391. PubMed ID: 28292214
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Tax-targeted DC vaccine for ATL].
    Suehiro Y
    Nihon Rinsho; 2017 Feb; 75(2):295-300. PubMed ID: 30562867
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA era.
    Mantha S; Goldman DA; Devlin SM; Lee JW; Zannino D; Collins M; Douer D; Iland HJ; Litzow MR; Stein EM; Appelbaum FR; Larson RA; Stone R; Powell BL; Geyer S; Laumann K; Rowe JM; Erba H; Coutre S; Othus M; Park JH; Wiernik PH; Tallman MS
    Blood; 2017 Mar; 129(13):1763-1767. PubMed ID: 28082441
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Physical Activity in Long-term Survivors of Acute Lymphoblastic leukemia in Childhood and Adolescence: A Cross-sectional Cohort Study.
    Nayiager T; Barr RD; Anderson L; Cranston A; Hay J
    J Pediatr Hematol Oncol; 2017 Jan; 39(1):15-19. PubMed ID: 27571119
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Modeling Chemotherapy Resistant leukemia In Vitro.
    Slone WL; Moses BS; Evans R; Piktel D; Martin KH; Petros W; Craig M; Gibson LF
    J Vis Exp; 2016 Feb; (108):e53645. PubMed ID: 26891147
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Mucormycosis during Imatinib treatment: case report.
    Crisan AM; Ghiaur A; Stancioaca MC; Bardas A; Ghita C; Manea CM; Ionescu B; Coriu D
    J Med Life; 2015; 8(3):365-70. PubMed ID: 26351543
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Fetuin-A levels and free leptin index are reduced in patients with chronic lymphocytic leukemia: a hospital-based case-control study.
    Dalamaga M; Polyzos SA; Karmaniolas K; Chamberland J; Lekka A; Triantafilli M; Migdalis I; Papadavid E; Mantzoros CS
    Leuk Lymphoma; 2016; 57(3):577-84. PubMed ID: 26317877
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Blocking the ZZ domain of sequestosome1/p62 suppresses myeloma growth and osteoclast formation in vitro and induces dramatic bone formation in myeloma-bearing bones in vivo.
    Teramachi J; Silbermann R; Yang P; Zhao W; Mohammad KS; Guo J; Anderson JL; Zhou D; Feng R; Myint KZ; Maertz N; Beumer JH; Eiseman JL; Windle JJ; Xie XQ; Roodman GD; Kurihara N
    Leukemia; 2016 Feb; 30(2):390-8. PubMed ID: 26286116
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Role of leptin and leptin receptors in hematological malignancies.
    Uddin S; Mohammad RM
    Leuk Lymphoma; 2016; 57(1):10-6. PubMed ID: 26077362
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.